Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...
Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare ...
Sebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell ...
While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing ...
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...
Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals ...
The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form of epilepsy, scientists have developed a new gene replacement therapy in ...
An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with a ...